Classification of Distinct Endotypes in Human Skin Scarring: S.C.A.R.—A Novel Perspective on Dermal Fibrosis
| Autor: | Ardeshir Bayat, Sara Ud-Din |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
0301 basic medicine
Treatment response Endotype medicine.medical_specialty Scars Human skin Disease Critical Care and Intensive Care Medicine Dermal fibrosis Cicatrix 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Humans Pathological Skin business.industry Atopic dermatitis Forum Review Articles medicine.disease Dermatology Asthma Phenotype 030104 developmental biology Emergency Medicine Atrophy medicine.symptom business |
| Zdroj: | Adv Wound Care (New Rochelle) Ud-din, S & Bayat, A 2021, ' Classification of distinct endotypes in human skin scarring: S. C. A. R.-A novel perspective on dermal fibrosis ', Advances in Wound Care . https://doi.org/10.1089/wound.2020.1364 |
| ISSN: | 2162-1934 2162-1918 |
| DOI: | 10.1089/wound.2020.1364 |
| Popis: | Significance: Skin scarring is a permanent, irreversible end point of cutaneous injury. However, not everyone will acquire the same exact scar type. Skin scarring is generally recognized as complex with significant variability in individuals' scar type and response to treatment. Despite these tangible differences in treatment response, to date there has been no simplified approach in defining spectrum of skin scarring in relation to prediction and outcome post-treatment. Thus, in this study we propose that skin scarring consists of distinct endotypes, which is characterized by their specific pathology. Four distinct scar endotypes can be observed: (1) Stretched (flat), (2) Contracted, (3) Atrophic (depressed), and (4) Raised scarring, which can be abbreviated to S.C.A.R. endotypes. Each of these endotypes can certainly include subphenotypes and each phenotype can be present in more than one endotype. To define these endotypes, we also present a structured approach in assessment of all relevant parameters in skin scar evaluation including clinical (scar symptoms and signs) and nonclinical parameters (device measurements of structural, mechanical, and physiological properties of scars as well as gene and protein laboratory studies). Recent Advances: Scars can be phenotypically characterized based on a multitude of parameters assessed; however, not all scar types will share all the same characteristics. This leads to the question of whether skin scarring is a single disease entity with varying phenotypic characteristics or should be classed as several disease entities that have certain similar parameters. We suggest the latter and propose distinct scarring phenotypes arise mainly owing to genetic and environmental susceptibilities associated with the development of each specific scar endotype. Characteristic features of skin scarring, however, can be objectively and quantitively evaluated and used as an aid in the theranostic goal-directed management of scarring. Critical Issues: The concept of identifying different endotypes is key in formulating personalized treatments with improved outcomes beyond what is achieved with current nonspecific approaches in scar management. This approach has gained interest and significant traction in several other medical conditions including asthma, rheumatoid arthritis, and atopic dermatitis. Future Directions: To begin identifying distinct endotypic features in skin scarring, it is important to have a better understanding of underlying pathological mechanisms leading to further insight into the heterogeneous nature of skin scarring endotypes. This approach may lead to improved theranostic outcomes and further understanding of the pathophysiology of the complex nature of human skin scarring. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|